Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Filters applied: . Clear all
Page 1
. 2023 Sep 12.
doi: 10.1097/CCM.0000000000006050. Online ahead of print.

National ICU Registries as Enablers of Clinical Research and Quality Improvement

Affiliations

National ICU Registries as Enablers of Clinical Research and Quality Improvement

Jorge I F Salluh et al. Crit Care Med. .

Abstract

Objectives: Clinical quality registries (CQRs) have been implemented worldwide by several medical specialties aiming to generate a better characterization of epidemiology, treatments, and outcomes of patients. National ICU registries were created almost 3 decades ago to improve the understanding of case-mix, resource use, and outcomes of critically ill patients. This narrative review describes the challenges, proposed solutions, and evidence generated by National ICU registries as facilitators for research and quality improvement.

Data sources: English language articles were identified in PubMed using phrases related to ICU registries, CQRs, outcomes, and case-mix.

Study selection: Original research, review articles, letters, and commentaries, were considered.

Data extraction: Data from relevant literature were identified, reviewed, and integrated into a concise narrative review.

Data synthesis: CQRs have been implemented worldwide by several medical specialties aiming to generate a better characterization of epidemiology, treatments, and outcomes of patients. National ICU registries were created almost 3 decades ago to improve the understanding of case-mix, resource use, and outcomes of critically ill patients. The initial experience in European countries and in Oceania ensured that through locally generated data, ICUs could assess their performances by using risk-adjusted measures and compare their results through fair and validated benchmarking metrics with other ICUs contributing to the CQR. The accomplishment of these initiatives, coupled with the increasing adoption of information technology, resulted in a broad geographic expansion of CQRs as well as their use in quality improvement studies, clinical trials as well as international comparisons, and benchmarking for ICUs.

Conclusions: ICU registries have provided increased knowledge of case-mix and outcomes of ICU patients based on real-world data and contributed to improve care delivery through quality improvement initiatives and trials. Recent increases in adoption of new technologies (i.e., cloud-based structures, artificial intelligence, machine learning) will ensure a broader and better use of data for epidemiology, healthcare policies, quality improvement, and clinical trials.

Conflict of interest statement

Dr. Beane received support for article research from Wellcome Trust/Charity Open Access Fund (COAF). Drs. Pilcher and Litton are members of the Australian and New Zealand Intensive Care Society Centre for Outcome and Resources Evaluation management committee. Drs Salluh is co-founder and shareholder of Epimed Solutions, a healthcare cloud-based analytics company. He is also supported, in part, by individual research grants from the National Council for Scientific and Technological Development and Research Support Foundation of the State of Rio de Janeiro. Dr. Dongelmans is unpaid chair of National Intensive Care Evaluation Foundation. Dr. Ichihara’s primary affiliation is the Department of Healthcare Quality Assessment, which is a social collaboration department at the University of Tokyo supported by National Clinical Database, Johnson & Johnson K.K., and Nipro Corporation. Dr. Vijayaraghavan is the National Coordinator for the Indian Registry of IntenSive Care and is supported for 0.5 full-time equivalent hours by funding from the Wellcome Trust, U.K. Dr. Bagshaw received funding from Baxter and BioPorto. Dr. Hashimoto’s institution received funding from the Japanese Ministry of Health, Labour and Welfare for the Japanese Intensive care PAtient Database (JIPAD), the Japanese Society of Intensive Care Medicine, and JMS. Dr. Haniffa’s institution received funding from Wellcome Trust/COAF and UK Research and Innovation (UKRI); he disclosed that he is an honorary director of National Intensive Care Surveillance MORU. Dr. Pisani received funding from Wellcome Trust and The African Critical Care registry network funded by this UKRI MRC (grant MR/V030884/1). The remaining authors have disclosed that they do not have any potential conflicts of interest.

Proceed to details
. 2023 May 24:thorax-2022-219592.
doi: 10.1136/thorax-2022-219592. Online ahead of print.

Non-COVID-19 intensive care admissions during the pandemic: a multinational registry-based study

Affiliations

Non-COVID-19 intensive care admissions during the pandemic: a multinational registry-based study

Joshua McLarty et al. Thorax. .

Abstract

Background: The COVID-19 pandemic resulted in a large number of critical care admissions. While national reports have described the outcomes of patients with COVID-19, there is limited international data of the pandemic impact on non-COVID-19 patients requiring intensive care treatment.

Methods: We conducted an international, retrospective cohort study using 2019 and 2020 data from 11 national clinical quality registries covering 15 countries. Non-COVID-19 admissions in 2020 were compared with all admissions in 2019, prepandemic. The primary outcome was intensive care unit (ICU) mortality. Secondary outcomes included in-hospital mortality and standardised mortality ratio (SMR). Analyses were stratified by the country income level(s) of each registry.

Findings: Among 1 642 632 non-COVID-19 admissions, there was an increase in ICU mortality between 2019 (9.3%) and 2020 (10.4%), OR=1.15 (95% CI 1.14 to 1.17, p<0.001). Increased mortality was observed in middle-income countries (OR 1.25 95% CI 1.23 to 1.26), while mortality decreased in high-income countries (OR=0.96 95% CI 0.94 to 0.98). Hospital mortality and SMR trends for each registry were consistent with the observed ICU mortality findings. The burden of COVID-19 was highly variable, with COVID-19 ICU patient-days per bed ranging from 0.4 to 81.6 between registries. This alone did not explain the observed non-COVID-19 mortality changes.

Interpretation: Increased ICU mortality occurred among non-COVID-19 patients during the pandemic, driven by increased mortality in middle-income countries, while mortality decreased in high-income countries. The causes for this inequity are likely multi-factorial, but healthcare spending, policy pandemic responses, and ICU strain may play significant roles.

Keywords: COVID-19; Clinical Epidemiology; Critical Care.

Conflict of interest statement

Competing interests: DP and Dr EL are members of the Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcome and Resources Evaluation management committee. AB is funded by Wellcome. JS and MS are cofounders and shareholders of Epimed Solutions, a healthcare cloud-based analytics company. They are also supported in part by individual research grants from CNPq and FAPERJ. SB is the current chair, and MR is the past chair of the Finnish Intensive Care Consortium (both unpaid). DAD is unpaid chair of NICE foundation. NI's primary affiliation is the Department of Healthcare Quality Assessment, which is a social collaboration department at the University of Tokyo supported by National Clinical Database, Johnson & Johnson K.K., and Nipro corporation. BKTV is the National Coordinator for the Indian Registry of IntenSive care (IRIS) and is supported for 0.5 FTE by funding from the Wellcome Trust, UK. The remaining authors have no conflicts of interest to declare.

Proceed to details